达安基因(002030.SZ)：不涉及违反外商投资相关法律法规的情形

Core Viewpoint - The company, Da An Gene (002030.SZ), confirmed that it does not violate any foreign investment laws and regulations [1] Group 1 - The Hong Kong Central Clearing and Settlement System, a wholly-owned subsidiary of the Hong Kong Stock Exchange, operates the central clearing and settlement system in Hong Kong [1] - The Hong Kong Central Clearing and Settlement System does not hold shares in substance but represents Hong Kong and overseas investors holding shares in A-shares through the Stock Connect programs [1] - The company is a constituent stock of the Shenzhen Stock Connect, and investors purchasing the company's stock through the Shenzhen Stock Connect will reflect under the account name of the Hong Kong Central Clearing and Settlement System [1]